Literature DB >> 33643055

The Study of Angptl4-Modulated Podocyte Injury in IgA Nephropathy.

Sha Jia1,2,3,4,5,6, Xiaofeng Peng1,2,3,4,5, Ludan Liang1,2,3,4,5, Ying Zhang1,2,3,4,5, Meng Li1,2,3,4,5, Qin Zhou1,2,3,4,5, Xiujin Shen1,2,3,4,5, Yucheng Wang1,2,3,4,5, Cuili Wang1,2,3,4,5, Shi Feng1,2,3,4,5, Jianghua Chen1,2,3,4,5, Pingping Ren1,2,3,4,5, Hong Jiang1,2,3,4,5.   

Abstract

BACKGROUND: Increasing evidence shows that Angptl4 affects proteinuria in podocytes injured kidney disease, however, whether there is a relationship between Angptl4 and IgA nephropathy (IgAN) has not been studied yet.
METHODS: Plasma and urine samples were obtained from 71 patients with IgAN and 61 healthy controls. Glomeruli from six renal biopsy specimens (three IgAN patients and three healthy controls) were separated by RNA-Seq. Differentially expressed genes (DEGs) related to podocytes and Angptl4 between IgAN patients and healthy controls were performed using the Limma package. Gene set enrichment analysis was used to determine whether there was a statistically significant difference between the two groups. STRING was used to create a protein-protein interaction network of DEGs. Association analysis between Angptl4 levels and clinical features of IgAN was performed.
RESULTS: Thirty-three podocyte-related and twenty-three Angpt4-related DEGs were found between IgAN patients and healthy controls. By overlapping the genes, FOS and G6PC were found to be upregulated in IgAN patients, while MMP9 was downregulated in IgAN patients. Plasma and urine Angptl4 levels were closely related to the degree of podocyte injury and urine protein, but not to the protein-creatine ratio.
CONCLUSION: Our findings show that Angptl4 levels in plasma and urine are related to podocyte damage and, therefore, may be a promising tool for assessing the severity of IgAN patients to identify and reverse the progression to ESRD.
Copyright © 2021 Jia, Peng, Liang, Zhang, Li, Zhou, Shen, Wang, Wang, Feng, Chen, Ren and Jiang.

Entities:  

Keywords:  Angptl4; RNA-Seq; immunoglobulin A nephropathy; podocyte; progression

Year:  2021        PMID: 33643055      PMCID: PMC7905042          DOI: 10.3389/fphys.2020.575722

Source DB:  PubMed          Journal:  Front Physiol        ISSN: 1664-042X            Impact factor:   4.566


  23 in total

1.  Advanced oxidation protein products activate intrarenal renin-angiotensin system via a CD36-mediated, redox-dependent pathway.

Authors:  Wei Cao; Jie Xu; Zhan Mei Zhou; Guo Bao Wang; Fan Fan Hou; Jing Nie
Journal:  Antioxid Redox Signal       Date:  2012-07-30       Impact factor: 8.401

Review 2.  Cell biology and pathology of podocytes.

Authors:  Anna Greka; Peter Mundel
Journal:  Annu Rev Physiol       Date:  2011-11-04       Impact factor: 19.318

3.  Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of matrix metalloproteinases 2 and 1 in the glomeruli of human glomerular diseases: the results of studies using immunofluorescence, in situ hybridization, and immunoelectron microscopy.

Authors:  Makiho Sekiuchi; Akihiko Kudo; Kimimasa Nakabayashi; Masami Kanai-Azuma; Yoshihiro Akimoto; Hayato Kawakami; Akira Yamada
Journal:  Clin Exp Nephrol       Date:  2012-05-22       Impact factor: 2.801

4.  Proteins induced by telomere dysfunction are associated with human IgA nephropathy.

Authors:  Ying-ying Lu; Xian Yang; Wen-qing Chen; Zhen-yu Ju; Zhang-fei Shou; Juan Jin; Xiao-hui Zhang; Jiang-hua Chen; Hong Jiang
Journal:  J Zhejiang Univ Sci B       Date:  2014-06       Impact factor: 3.066

5.  Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome.

Authors:  Lionel C Clement; Camille Macé; Carmen Avila-Casado; Jaap A Joles; Sander Kersten; Sumant S Chugh
Journal:  Nat Med       Date:  2013-12-08       Impact factor: 53.440

6.  Upregulation of podocyte-secreted angiopoietin-like-4 in diabetic nephropathy.

Authors:  Jing Ma; Xiao Chen; Jian-Si Li; Lei Peng; Shi-Yao Wei; Shi-Lei Zhao; Tong Li; Dan Zhu; Yi-Xin He; Qiu-Ju Wei; Bing Li
Journal:  Endocrine       Date:  2014-11-26       Impact factor: 3.633

7.  Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease.

Authors:  Hong Jiang; Eric Schiffer; Zhangfa Song; Jianwei Wang; Petra Zürbig; Kathrin Thedieck; Suzette Moes; Heike Bantel; Nadja Saal; Justyna Jantos; Meiken Brecht; Paul Jenö; Michael N Hall; Klaus Hager; Michael P Manns; Hartmut Hecker; Arnold Ganser; Konstanze Döhner; Andrzej Bartke; Christoph Meissner; Harald Mischak; Zhenyu Ju; K Lenhard Rudolph
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-11       Impact factor: 11.205

8.  Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schönlein-Henoch purpura nephritis.

Authors:  Masanori Hara; Toshio Yanagihara; Itaru Kihara
Journal:  Clin J Am Soc Nephrol       Date:  2007-01-31       Impact factor: 8.237

9.  Angiopoietin-Like-4, a Potential Target of Tacrolimus, Predicts Earlier Podocyte Injury in Minimal Change Disease.

Authors:  Jian-Si Li; Xiao Chen; Lei Peng; Shi-Yao Wei; Shi-Lei Zhao; Tian-Tian Diao; Yi-Xin He; Fang Liu; Qiu-Ju Wei; Qing-Fang Zhang; Bing Li
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

10.  Functional networks of aging markers in the glomeruli of IgA nephropathy: a new therapeutic opportunity.

Authors:  Hong Jiang; Ludan Liang; Jing Qin; Yingying Lu; Bingjue Li; Yucheng Wang; Chuan Lin; Qin Zhou; Shi Feng; Shun H Yip; Feng Xu; En Yin Lai; Junwen Wang; Jianghua Chen
Journal:  Oncotarget       Date:  2016-06-07
View more
  1 in total

1.  TNF-α-mediated podocyte injury via the apoptotic death receptor pathway in a mouse model of IgA nephropathy.

Authors:  Qiang Wan; Jiabao Zhou; Yansheng Wu; Liqiang Shi; Weiwei Liu; Jiaoying Ou; Jiandong Gao
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.